Ketamine Clinic Marketing Rules: A Compliance Guide

What Are the Marketing Rules for Ketamine Clinics?

There is no single rulebook for ketamine clinic marketing. Several sets of rules apply at once: what the FDA has approved, the FTC’s rules on truthful advertising, your state medical board, the policies of Google and Meta, and privacy law.

The starting point is product status. In its 2023 warning on compounded ketamine, the FDA said: “Ketamine is not FDA approved for the treatment of any psychiatric disorder.” Doctors can generally prescribe an approved drug for an unapproved use, but that doesn’t make every way of advertising it acceptable. Your marketing needs to keep prescribing, product approval and advertising permission separate.

How Do You Market a Ketamine Clinic Within the Rules?

Describe each treatment accurately and support every claim before you publish. Check each platform’s rules for your business model. Keep patient data out of ad tools, and record who reviewed your marketing and when.

Ketamine clinic marketing compliance in three steps and seven tasks

Step 1: Get the facts right
Describe each treatment accurately: IV ketamine, Spravato and at-home ketamine are kept separate.
Back up every claim: each benefit you state has evidence behind it.
Testimonials and reviews: patient stories don’t promise results others may not get.
Step 2: Check each channel
Google Ads: you know what your business model allows before you spend.
Facebook and Instagram: your ads, posts and partnerships follow Meta’s separate rules.
Your website and tracking: sensitive data stays out of ad platforms.
Step 3: Review before you publish
A claim-review record: every claim has a reviewer, a date and a reason to recheck it.

Step 1: Get the Facts Right

Every rule below depends on describing your treatment correctly.

1. Describe Each Treatment Accurately

Ketamine, Spravato and compounded ketamine have different FDA status. Keep them apart in every ad and page:

Treatment	FDA status (checked October 24, 2026)	Wrong	More accurate wording to review
FDA-approved ketamine injection, given by IV or IM	Approved as a general anesthetic (Ketalar). Use for depression is off-label	“FDA-approved ketamine therapy for depression”	“Ketamine infusions for depression use an FDA-approved anesthetic off-label”
Spravato (esketamine nasal spray)	Approved for adults with treatment-resistant depression, alone or with an oral antidepressant. Also approved, with an oral antidepressant, for depressive symptoms in adults with major depression and acute suicidal thoughts or behavior	“Spravato cures depression”	“Spravato is FDA-approved for adults with treatment-resistant depression”
Compounded ketamine (nasal sprays, troches or lozenges, at-home products)	Not FDA-approved. The FDA hasn’t reviewed their safety, effectiveness or quality	“Safe at-home ketamine, approved by doctors”	“Compounded ketamine is not FDA-approved. Discuss the evidence, risks and treatment options with the prescribing clinician”

These examples cover approval wording only. Any ad still needs evidence for its claims, important risk information and review under the rules of its channel. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior.

Spravato also has a safety program, called a Risk Evaluation and Mitigation Strategy (REMS). It must be given in a certified healthcare setting, and patients are monitored for at least two hours. Being certified for Spravato doesn’t approve your other ketamine services.

FDA enforcement is real. In June 2026 the FDA sent a warning letter to an online seller over “unapproved and misbranded ketamine drug products” and the claims on its website.

Example from our work: for EleMental Health, a new ketamine and IV therapy clinic in Boise, Idaho, we built an introduction to the clinic and separate pages for each condition. Ahrefs estimated their monthly search visits grew from 0 in February 2026 to 133 in September 2026, and the site ranked #3 for “ketamine therapy boise” in the September snapshot. These are visibility estimates, not counts of patients, and they say nothing about whether a claim is compliant.

Check every page and ad against this table before anything else.

2. Back Up Every Claim

The FTC says health claims must be truthful, not misleading and backed by “competent and reliable scientific evidence” before you publish them. For health-benefit claims, the FTC generally expects well-designed randomized, controlled human clinical trials. The evidence must support the specific treatment, patients and result described. A citation or a disclaimer on its own isn’t proof.

The FTC looks at the overall impression, including images and what you leave out, not just the exact words. Common problem claims:

Cure or guarantee: “End your depression for good.”
Speed: “Feel better in hours” stated as a promise.
Success rates: “90% of our patients improve,” without data that supports it.
Safety: “No side effects” or “completely safe”.
Credentials: a training certificate presented as “board certified”.

Professional and state rules point the same way. The American Medical Association’s ethics guidance says physician advertising must be “true and not materially misleading.” The American Society of Ketamine Physicians, Psychotherapists and Practitioners (ASKP3) says efficacy claims “should be provisional.” California’s law on healing-arts advertising, as one state example, covers misleading statements, unjustified expectations and testimonials, and the state medical board treats misleading advertising as unprofessional conduct.

Have a clinician check every benefit you state, and keep the evidence on file.

3. Testimonials and Reviews

Check evidence, permission and disclosures before you use a patient story.

Typical results: under the FTC’s Endorsement Guides, if a testimonial shows an unusual result, you need evidence that it is generally expected, or you must clearly say what patients can generally expect. “Results may vary” isn’t enough.
Connections and incentives: clearly disclose any payment, free service or other relationship that could affect how readers judge the endorsement.
Fake or bought reviews: the FTC’s Consumer Reviews and Testimonials Rule, in effect since October 2024, bans fake reviews and incentives that depend on a positive or negative review. As a clinic policy, it’s safest to avoid review incentives altogether.
Asking for reviews: don’t ask only patients you expect to be happy, and don’t hide negative reviews.
Patient permission: if your practice is covered by HIPAA, using identifiable patient information in public marketing generally requires a valid HIPAA authorization. Have your privacy lead check it.
Replies: never confirm that someone is a patient when you reply to a review.

Use only stories you can stand behind, with permission on file, connections disclosed and typical results made clear.

Step 2: Check Each Channel

Each platform has its own rules, and they depend on how your clinic works: in-person only, telehealth, or both.

4. Google Ads

Ketamine is a prescription drug, so Google’s prescription drug rules apply, and they change with your business model:

Your model	What Google’s US policies say
In-person clinic	Prescription drug names can appear in ads and landing pages without certification. Bidding on drug names as keywords requires certification
Telehealth that may lead to a prescription	Needs LegitScript Healthcare Merchant certification and Google’s own certification
Compounded or at-home products	Google prohibits promoting products covered by its unapproved substances policy, including products that aren’t government-approved but are marketed as safe or effective for treating disease. Confirm how Google classifies your specific offer. Certification doesn’t override this
A clinic that also treats addiction	Addiction services have a separate certification. Our drug rehab advertising guide covers it

LegitScript’s current FAQ says in-person-only clinics that don’t offer telemedicine prescribing or take card-not-present payments for prescription drugs are generally not eligible for its healthcare certification. It also says it “cannot determine whether an advertising platform will approve or deny advertisements for ketamine-related content.” Certification and ad approval are separate decisions.

Google also limits targeting for health topics. You can’t use advertiser-curated audiences, such as patient lists or retargeting lists, for ads about mental health treatment.

Confirm which model you are before you build a campaign, and never use wording designed to get around a review.

5. Facebook and Instagram

Meta has three separate sets of rules to check:

Prescription drugs: for prescription drug ads, eligible online pharmacies and telehealth providers need active LegitScript certification and separate authorization from Meta. They must complete Meta’s onboarding, meet its licensing and country rules, target adults 18 or older, and tell people to consult a licensed health professional or get a valid prescription. Even then, a ketamine ad isn’t guaranteed approval.
Personal attributes: ads must not assert or imply a personal attribute, including mental health. “Tired of your depression?” implies the viewer has a condition. “Ketamine infusions for depression, by consultation” avoids that, but it is only an example of the wording rule. The treatment, advertiser, ad and website still need to meet Meta’s other rules.
Branded content: paid partnerships with influencers follow different rules from ads. In 2023 Meta’s Oversight Board ruled that a paid Instagram partnership promoting ketamine for unapproved uses broke Meta’s branded content policy and should come down.

Review each format on its own: organic posts, paid partnerships and paid ads.

6. Your Website and Tracking

Ad pixels and tracking tools can send sensitive data to platforms without anyone noticing.

Meta’s Business Tools Terms prohibit sending health information through the pixel or Conversions API, including event names that imply it. Hashing the data or signing a business associate agreement (BAA) doesn’t change that.
HHS tracking guidance: in June 2024 a court vacated the part of HHS’s guidance about linking an IP address to a visit to a public health page. HIPAA still applies to covered practices and their business associates when tracking collects or shares protected health information, such as from intake forms or patient portals.
Forms and calls: keep diagnosis, treatment choice and patient status in your own secure systems, not in ad or analytics tools.

Have your privacy lead review what each form, chat and tracking tag sends, and to whom.

Every clinic’s mix of treatments and channels is different. If it would help to work out where your marketing needs review, we can go through it together. It’s a free conversation, with no obligation.Let’s Review Your Marketing

Step 3: Review Before You Publish

Rules change, and so do your services. A simple record keeps your claims current.

7. A Claim-Review Record

Keep one row for each claim, ad or page before it goes live:

Field	What to record
Claim	The exact wording and a screenshot
Where	Channel, audience and states
Treatment	Product, route and service model (in-person, telehealth or both)
Takeaway	What a reader would understand, stated and implied
Evidence	The study or label section that supports it, and its limits
Testimonial check	Authorization on file, any material connection and its public disclosure, evidence for stated typical results
Data	What personal data the page or ad collects and where it goes
Reviewer	Who approved it: clinician, legal counsel or privacy lead
Dates	Approval date and the date to recheck

Recheck a claim when you change a treatment, add a state, change a form or tracking tool, or when a platform policy changes. Some dates are fixed: the DEA’s temporary telemedicine flexibilities for prescribing controlled substances, which include ketamine, currently run through December 31, 2026.

Give one person the job of keeping this record up to date.

Ketamine Clinic Marketing: What to Check

When something goes wrong, start from what you see:

What you see	Look at	First check
A Google ad was disapproved	Your business model and keywords	Are you bidding on drug names, or offering telehealth prescribing, without certification?
A Meta ad was rejected	The ad, the advertiser and the disclosures	Does it imply a health condition? Is the advertiser eligible, with the required certification, Meta authorization and disclosures?
A page says “FDA-approved ketamine”	Your treatment descriptions	Does the claim match the actual product’s FDA status?
A testimonial shows a dramatic result	The typical-results check	Is it generally expected, or do you clearly state typical results?
Ad tools receive form data	Your tracking setup	Do any events or fields reveal health information?
No one knows who approved a claim	Your claim-review record	Is there a reviewer, date and recheck date for it?

Want a Second Opinion on Your Ketamine Clinic Marketing?

If it would help to talk it through, we’re happy to look at your website, ads and tracking and suggest where we would start. You can also see how we work on our ketamine clinic marketing page.

Book a Free Call

Ketamine Clinic Marketing Rules: Common Questions

Is ketamine FDA-approved for depression?

Not racemic ketamine. Ketamine is approved as an anesthetic, and its use for depression is off-label. Spravato (esketamine) is FDA-approved for adults with treatment-resistant depression, alone or with an oral antidepressant. Compounded ketamine products, including many at-home forms, are not FDA-approved. Your marketing should keep these apart.

Can ketamine clinics advertise on Google?

Possibly, depending on the service. In the US, ads and landing pages can name prescription drugs, but bidding on drug names as keywords needs certification. Telehealth prescribing also needs LegitScript and Google certification. Offers covered by Google’s unapproved substances policy can’t be promoted. Check your actual services and website before you commit a budget.

Can ketamine clinics run Facebook ads?

Possibly, depending on the service and advertiser. Prescription drug ads from eligible telehealth providers and online pharmacies need LegitScript certification, Meta authorization, required disclosures and adult targeting. Ads must not imply the viewer has a condition, and health data can’t go through Meta’s business tools. Certification doesn’t guarantee approval of a ketamine ad.

Do ketamine clinics need LegitScript certification?

It depends on your model. LegitScript’s healthcare certification covers telehealth prescribing and some online prescription activity. In-person-only clinics without qualifying online prescription activity are generally not eligible. In October 2026, standard fees were $975 to apply and $2,150 a year per website. Certification doesn’t guarantee that Google or Meta will approve your ads.

Can we use patient testimonials?

Yes, carefully. Get a valid authorization from the patient. Under the FTC’s Endorsement Guides, an unusual result needs evidence that it is typical, or a clear statement of what patients can generally expect. “Results may vary” isn’t enough. Disclose any connection, don’t ask only happy patients and never confirm someone is a patient in replies.

Sources

Checked October 24, 2026. This page is general information, not legal, medical or compliance advice. Have a qualified professional review your marketing.